Modulatory effects of quercetin on proliferation and differentiation of the human colorectal cell line Caco-2. 2006

Ashwin A Dihal, and Ruud A Woutersen, and Ben van Ommen, and Ivonne M C M Rietjens, and Rob H Stierum
Physiological Sciences Department, TNO Quality of Life, Zeist, The Netherlands. dihal@voeding.tno.nl

The effect of the dietary flavonoid quercetin was investigated on proliferation and differentiation of the human colon cancer cell line Caco-2. Confluent Caco-2 monolayers exposed to quercetin showed a biphasic effect on cell proliferation and a decrease in cell differentiation (0.001<P<0.05). During differentiation Caco-2 cells formed 5 phase II metabolites, of which the amount of 4'-O-methyl-quercetin-3'-O-glucuronide correlated with the differentiation grade (r=0.99, P<0.003). The increment of cell proliferation at low quercetin concentrations and the decrease in cell differentiation are effects opposite to what would be expected for a functional food ingredient with anti-carcinogenic potential.

UI MeSH Term Description Entries
D011794 Quercetin A flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin. 3,3',4',5,7-Pentahydroxyflavone,Dikvertin
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal
D016588 Anticarcinogenic Agents Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. Anti-Carcinogenic Agents,Anti-Carcinogenic Drugs,Anti-Carcinogenic Effect,Anti-Carcinogenic Effects,Anticarcinogenic Drugs,Anticarcinogenic Effect,Anticarcinogenic Effects,Anticarcinogens,Agents, Anti-Carcinogenic,Agents, Anticarcinogenic,Anti Carcinogenic Agents,Anti Carcinogenic Drugs,Anti Carcinogenic Effect,Anti Carcinogenic Effects,Drugs, Anti-Carcinogenic,Drugs, Anticarcinogenic,Effect, Anti-Carcinogenic,Effect, Anticarcinogenic,Effects, Anti-Carcinogenic,Effects, Anticarcinogenic
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D018938 Caco-2 Cells Human colonic ADENOCARCINOMA cells that are able to express differentiation features characteristic of mature intestinal cells, such as ENTEROCYTES. These cells are valuable in vitro tools for studies related to intestinal cell function and differentiation. Caco 2 Cells,Caco-2 Cell,Cell, Caco-2,Cells, Caco-2

Related Publications

Ashwin A Dihal, and Ruud A Woutersen, and Ben van Ommen, and Ivonne M C M Rietjens, and Rob H Stierum
November 1998, Carcinogenesis,
Ashwin A Dihal, and Ruud A Woutersen, and Ben van Ommen, and Ivonne M C M Rietjens, and Rob H Stierum
August 2003, Biochimica et biophysica acta,
Ashwin A Dihal, and Ruud A Woutersen, and Ben van Ommen, and Ivonne M C M Rietjens, and Rob H Stierum
July 2001, Cytotechnology,
Ashwin A Dihal, and Ruud A Woutersen, and Ben van Ommen, and Ivonne M C M Rietjens, and Rob H Stierum
July 1998, Digestive diseases and sciences,
Ashwin A Dihal, and Ruud A Woutersen, and Ben van Ommen, and Ivonne M C M Rietjens, and Rob H Stierum
January 2004, Chinese journal of digestive diseases,
Ashwin A Dihal, and Ruud A Woutersen, and Ben van Ommen, and Ivonne M C M Rietjens, and Rob H Stierum
August 2017, Cytotechnology,
Ashwin A Dihal, and Ruud A Woutersen, and Ben van Ommen, and Ivonne M C M Rietjens, and Rob H Stierum
January 2000, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract,
Ashwin A Dihal, and Ruud A Woutersen, and Ben van Ommen, and Ivonne M C M Rietjens, and Rob H Stierum
May 1993, The Journal of biological chemistry,
Ashwin A Dihal, and Ruud A Woutersen, and Ben van Ommen, and Ivonne M C M Rietjens, and Rob H Stierum
April 1994, Endocrinology,
Ashwin A Dihal, and Ruud A Woutersen, and Ben van Ommen, and Ivonne M C M Rietjens, and Rob H Stierum
September 2008, Pharmaceutical research,
Copied contents to your clipboard!